First Infliximab Biosimilar registered in India
EPIRUS Biopharmaceuticals, Inc. announced that it has received final marketing and manufacturing approvals for its Remicade (infliximab) biosimilar, BOW015, from the Drug Controller General of India (DCGI). ...FDA Accepts Sandoz Application for Biosimilar Filgrastim
Sandoz, a Novartis Group company, has announced that FDA has accepted its Biologics Licence Application for filgrastim, which was filed under the new biosimilar pathway created in the Biologics Price ...Consensus Document On Biosimilar Medicines Paper Is Now Available In Five Languages
Brussels, 25 June 2014 - After its successful launch in May 2013, the European Consensus Information Paper What you need to know about Biosimilar Medicinal Products is now available in English, French, German, ...
Medizone Germany GmbH · Keltenring 15 · 82041 Oberhaching · Germany · Phone +49(0)89/12112636 · Fax +49(0)89/12112637 · Impressum · Datenschutz · Imprint · Privacy Policy